Sponsored By

A little more than one week after announcing the formation of Freudenberg Medical (Carpenteria, CA), Freudenberg's umbrella brand for Helix Medical and MedVenture Technology, the company has announced the acquisition of majority shares in Hemoteq AG (Würselen, Germany).

PlasticsToday Staff

August 19, 2015

1 Min Read
Freudenberg Medical acquires majority shares in surface treatment company

A little more than one week after announcing the formation of Freudenberg Medical (Carpenteria, CA), Freudenberg's umbrella brand for Helix Medical and MedVenture Technology, the company has announced the acquisition of majority shares in Hemoteq AG (Würselen, Germany). A provider of surface coating and related services for drug-eluting stents, catheters, cochlear implants and other medical devices, Hemoteq's capabilities are a good fit with Helix's medical molding and extrusion services and MedVenture's specialization in minimally invasive technology.

Hemoteq"Hemoteq's coating technology adds a key technology component to our portfolio and represents an important milestone in our long-term strategy to provide a full suite of innovative technology services to our global medical device OEM customers," said Jorg Schneewind, President and CEO of Freudenberg Medical.

Hemoteq provides comprehensive services from the development of the medical device to regulatory approval and serial production. The company holds more than 100 patents in surface treatment technologies. Freudenberg Medical develops and manufactures minimally invasive systems as well as components made of silicone, thermoplastics, and specialty metals; those surfaces can be modified with active-ingredient coatings for optimal efficiency of the medical device.

Under the transaction, Freudenberg Medical will acquire 75% of Hemoteq AG from current shareholders, Earlybird Venture Capital and Pinova Capital. The remaining shares are held by the founders of Hemoteq, Michael Hoffmann and Roland Horres, who together with the CFO, Thomas Löwen, will continue management of the company. Max Kley, President of Freudenberg Medical Europe and Specialty Components, will become Chairman of the Supervisory Board.

Sign up for the PlasticsToday NewsFeed newsletter.

You May Also Like